Clinical trial for prostate cancer awarded 2020 ACTA Trial of The Year
The Australian Clinical Trials Alliance (ACTA) has recognised the remarkable Australians who advance the health…
Browsing: Prostate Cancer
Prostate cancer: CRYM protein inhibits tumour growth
Prostate cancer is caused by elevated hormone levels, and tumours are generally treated using hormone…
Gene signature predicts whether localised prostate cancer is likely to spread
Researchers have identified a genetic signature in localised prostate cancer that can predict whether the…
Low risk of cancer spread on active surveillance for early prostate cancer
Men undergoing active surveillance for prostate cancer have very low rates – one percent or…
Prostate cancer drug targeting Achilles heel approved in Europe
The Institute of Cancer Research, London, UK, has strongly welcomed the approval by the European…
Prostate cancer drug targeting Achilles heel approved in Europe
The Institute of Cancer Research, London, UK, has strongly welcomed the approval by the European…
ICR welcomes NICE’s decision to reassess abiraterone as first-line treatment for advanced prostate cancer
The Institute of Cancer Research, London, UK, has welcomed the announcement by NICE that it…
Study examines health literacy and shared decision-making in prostate cancer screening
New research examines the dynamics between men’s health literacy, their discussions with their doctors, and…
Olaparib approved in Europe for prostate cancer
The Institute of Cancer Research, London, UK, has strongly welcomed the approval by the European…
Cancer Experts Welcome Medicare Changes to Empower Men with Prostate Cancer
The Royal Australian and New Zealand College of Radiologists (RANZCR), the Urological Society of Australia…